⌘K

Login Start Free

Home/Filings/144/0001178937-25-000089

144//SEC Filing

Kymera Therapeutics, Inc. 144

Accession 0001178937-25-000089

CIK 0001628098other

View on SEC.gov Company Profile

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 5:01 PM ET

Size

5.1 KB

Accession

0001178937-25-000089

Documents

1 file

144
primary_doc.xmlPrimary

Issuer

Atlas Venture Fund X, L.P.

CIK 0001628098

Entity typeother

IncorporatedDE

Related Parties

1

filerCIK 0001628098

Filing Metadata

Form type: 144
Filed: Dec 10, 7:00 PM ET
Accepted: Dec 11, 5:01 PM ET
Size: 5.1 KB

View on SEC.gov